These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23547816)

  • 1. The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients.
    van Dijk WD; Akkermans R; Heijdra Y; Weel Cv; Schermer TR; Scheepers PT; Lenders JW
    Biomark Med; 2013 Apr; 7(2):211-9. PubMed ID: 23547816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease.
    Tofan F; Rahimi-Rad MH; Rasmi Y; Rahimirad S
    Pneumologia; 2012; 61(3):160-2. PubMed ID: 23175870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
    Thomsen M; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    Am J Respir Crit Care Med; 2012 Nov; 186(10):982-8. PubMed ID: 22983959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
    Huang W; Chen QW; Lei H; Deng W; Ke DZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease.
    Biljak VR; Rumora L; Cepelak I; Pancirov D; Popović-Grle S; Sorić J; Stjepanović G; Grubisić TZ
    Coll Antropol; 2013 Mar; 37(1):221-7. PubMed ID: 23697277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi.
    Sharma SK; Mishra HK; Sharma H; Goel A; Sreenivas V; Gulati V; Tahir M
    Sleep Med; 2008 Jan; 9(2):149-56. PubMed ID: 17638590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
    Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
    Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High levels of high-sensitivity C-reactive protein and impaired autonomic activity in smokers].
    Alyan O; Kaçmaz F; Ozdemir O; Karahan Z; Taşkesen T; Iyem H; Alan S; Karadede A; Ilkay E
    Turk Kardiyol Dern Ars; 2008 Sep; 36(6):368-75. PubMed ID: 19155639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of obstructive sleep apnea and its treatment on cardiovascular risk in CAD patients.
    Zhao Q; Liu ZH; Zhao ZH; Luo Q; McEvoy RD; Zhang HL; Wang Y
    Respir Med; 2011 Oct; 105(10):1557-64. PubMed ID: 21646006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expressions and significance of APN, D-D, IL-17 and hs-CRP in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Ding GZ; Li WS
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6463-6468. PubMed ID: 30338815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
    Breyer MK; Rutten EP; Locantore NW; Watkins ML; Miller BE; Wouters EF;
    Eur J Clin Invest; 2012 Sep; 42(9):983-91. PubMed ID: 22703238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein is associated with cigarette smoking-induced hyperfiltration and proteinuria in an apparently healthy population.
    Sauriasari R; Sakano N; Wang DH; Takaki J; Takemoto K; Wang B; Sugiyama H; Sato Y; Takigawa T; Takahashi N; Kanbara S; Hitomi Y; Nakamura H; Ogino K
    Hypertens Res; 2010 Nov; 33(11):1129-36. PubMed ID: 20703235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
    Komnata K
    Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.
    Piché ME; Lemieux S; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J
    Am J Cardiol; 2005 Jul; 96(1):92-7. PubMed ID: 15979442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters in Indian type 2 diabetic males.
    Sarangi R; Padhi S; Mohapatra S; Swain S; Padhy RK; Mandal MK; Patro SK; Kumar S
    Diabetes Metab Syndr; 2012; 6(1):9-14. PubMed ID: 23014248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.